Search

Your search keyword '"Corda, Marco"' showing total 138 results

Search Constraints

Start Over You searched for: Author "Corda, Marco" Remove constraint Author: "Corda, Marco"
138 results on '"Corda, Marco"'

Search Results

1. Right ventricular phenotyping in incident patients with idiopathic pulmonary arterial hypertension

2. Gaps in evidence in the treatment of prevalent patients with pulmonary arterial hypertension at intermediate risk: An expert consensus

3. Hemodynamics and risk assessment 2 years after the initiation of upfront ambrisentan‒tadalafil in pulmonary arterial hypertension

6. Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) scientific statement on the simplification of the drug regimen for secondary cardiovascular prevention

7. Italian Association of Hospital Cardiologists position paper—obesity in adults: a clinical primer

8. ANMCO/SIMEU consensus document on the use of reversal agents for antithrombotic therapies in patients with ongoing bleeding or at high risk of haemorrhagic events

10. ANMCO position paper: guide to the appropriate use of the wearable cardioverter defibrillator in clinical practice for patients at high transient risk of sudden cardiac death

11. ANMCO position paper on the management of hypercholesterolaemia in patients with acute coronary syndrome

16. 347 ARRHYTHMIC MITRAL VALVE PROLAPSE AND MITRAL ANNULUS DISJUNCTION: WHEN PRIMARY PREVENTION IMPLANTATION OF ICD IS POSSIBLE?

17. 397 HEART FAILURE WITH REDUCE VENTRICULAR EJECTION FRACTION FOLLOWING THERAPY WITH RITUXIMAB IN A PATIENT AFFECTED BY MPO ANCA RELATED MICROSCOPIC POLYANGITIIS

21. 121 RELEVANCE OF COMORBIDITIES ON INITIAL COMBINATION THERAPY IN PULMONARY ARTERIAL HYPERTENSION

23. Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertension

24. The impact of UEFA Euro 2020 football championship on Takotsubo Syndrome: Results of a multicenter national registry

26. ANMCO statement on the use of sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a practical guide for a streamlined implementation

27. ANMCO position paper on antithrombotic treatment of patients with atrial fibrillation undergoing intracoronary stenting and/or acute coronary syndromes

28. ANMCO position paper: 2022 focused update of appropriate use criteria for multimodality imaging: aortic valve disease

29. ANMCO position paper ‘Appropriateness of prescribing direct oral anticoagulants in stroke and systemic thromboembolism prevention in adult patients with non-valvular atrial fibrillation’

30. The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner?

34. ANMCO POSITION PAPER: Prognostic and therapeutic relevance of non-obstructive coronary atherosclerosis

35. Risk reduction and hemodynamics with initial combination therapy in pulmonary arterial hypertension

36. Risk Reduction and Hemodynamics with Initial Combination Therapy in Pulmonary Arterial Hypertension

40. Ambrisentan and tadalafil as initial combination therapy for pulmonary arterial hypertension: clinical effect and haemodynamic changes. An Italian multicenter retrospective analysis

41. Clinical Spectrum, Therapeutic Options, and Outcome of Advanced Heart Failure in Hypertrophic Cardiomyopathy

45. Contrast-Enhanced Harmonic Color Doppler for Left Ventricular Opacification: Improved Endocardial Border Definition Compared to Tissue Harmonic Imaging and Optimization of Methodology in Patients with Suboptimal Echocardiograms

46. Risk reduction and hemodynamics with initial combination therapy in pulmonary arterial hypertension

48. Relevance of tricuspid annular plane systolic excursion/pulmonary artery systolic pressure ratio for risk assessment in pulmonary arterial hypertension

49. Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertension

50. Risk Reduction and Hemodynamics with Initial Combination Therapy in Pulmonary Arterial Hypertension

Catalog

Books, media, physical & digital resources